notice Published 2026-02-02

Certain Medical Imaging Devices; Notice of Institution of Investigation

Origins: CA

📌 ETDETA brief — importer impact summary (educational)

Brief takeaway: The ITC has opened a Section 337 investigation into certain medical imaging devices alleged to infringe a U.S. patent, which could eventually lead to import restrictions.

What changed: According to the notice, a complaint was filed on December 29, 2025 (and supplemented in January 2026) on behalf of MolecuLight Inc. of Canada and MolecuLight Corp. of Pittsburgh, Pennsylvania under Section 337 of the Tariff Act of 1930. The notice states the complaint alleges unlawful importation, sale for importation, and post-importation sale of certain medical imaging devices that infringe claims of U.S. Patent No. 10,438,356, and that the complainant requests a limited exclusion order and cease and desist orders.

Who's affected: The notice names certain medical imaging devices as the products at issue. It cites Canada as a country associated with the complainant; specific origins of accused imports and HTS codes are not specified in the notice. No respondents are named in this text.

What to review:
- Review whether your imported medical imaging devices could fall within the scope described in the complaint.
- Confirm with your broker or trade counsel whether the '356 patent may be relevant to products you import.
- Check the ITC docket for updates, named respondents, and any exclusion or cease and desist orders as the investigation proceeds.

This is general information, not legal advice and not a compliance determination — confirm specifics with a licensed customs broker or trade counsel.

Official notice

Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on December 29, 2025, under section 337 of the Tariff Act of 1930, as amended, on behalf of MolecuLight Inc. of Canada and MolecuLight Corp. of Pittsburgh, Pennsylvania. Supplements to the complaint were filed on January 12, 14, and 20, 2026. The complaint, as supplemented, alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain medical imaging devices by reason of the infringement of certain claims of U.S. Patent No. 10,438,356 ("the '356 patent"). The complaint, as supplemented, further alleges that an industry in the United States exists as required by the applicable Federal Statute. The complainant requests that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.

Source: Federal Register · International Trade Commission · Read the official notice ↗

Check how this affects your product

Run a U.S. import compliance self-check → Check an HTS classification → Estimate duty & landed cost →

Need help moving this shipment?

ETDETA coordinates the logistics side of your U.S. import — booking, ocean freight, inland transportation, and customs-clearance coordination through licensed customs brokers.

Get a Full Freight Quote →

Related updates

This update is a general educational summary based on public CBP CSMS / Federal Register information. It is not legal advice, customs broker advice, a final classification, duty determination, entry instruction, or compliance determination. Importers should confirm applicability, effective dates, HTSUS/Chapter 99 reporting, rates, refunds, PSC procedures, and filing instructions with their licensed customs broker, trade counsel, and/or CBP.